Patent details
EP2957292
Title:
THERAPY FOR VITILIGO
Basic Information
- Publication number:
- EP2957292
- PCT Application Number:
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP151705720
- PCT Publication Number:
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- THERAPY FOR VITILIGO
- French Title of Invention:
- THERAPIE POUR LE VITILIGO
- German Title of Invention:
- VITILIGO-BEHANDLUNG
- SPC Number:
-
Dates
- Filing date:
- 27/03/2009
- Grant date:
- 13/12/2017
- EP Publication Date:
- 23/12/2015
- PCT Publication Date:
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 13/12/2017
- EP B1 Publication Date:
- 13/12/2017
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 27/03/2018
- Expiration date:
- 27/03/2029
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 06/12/2017
-
-
- Name:
- Clinuvel Pharmaceuticals Limited
- Address:
- Level 6, 15 Queen Street, Melbourne, VIC 3000, Australia (AU)
Agent
- Name:
- Office FREYLINGER S.A.
- From:
- 28/12/2017
- Address:
- PO Box 48, 8001, STRASSEN, Luxembourg (LU)
- To:
Inventor
- Name:
- Wolgen, Philippe
- Address:
- Australia (AU)
Priority
- Priority Number:
- 2008901461
- Priority Date:
- 27/03/2008
- Priority Country:
- Australia (AU)
Classification
- IPC classification:
-
A61K 9/00;
A61K 31/37;
A61K 31/436;
A61K 31/485;
A61K 31/505;
A61K 31/52;
A61K 31/573;
A61K 31/58;
A61K 38/13;
A61K 38/21;
A61K 38/34;
A61K 45/06;
A61N 5/06;
A61P 17/00;
C07K 14/685;
Publication
European Patent Bulletin
- Issue number:
- 201750
- Publication date:
- 13/12/2017
- Description:
- Grant (B1)
Annual Fees
- Annual Fee Due Date:
-
- Annual Fee Number:
-
- Expected Payer:
-
- Last Annual Fee Payment Date:
-
- Last Annual Fee Paid Number:
-
- Payer:
-